COBAS AMPLICOR CT/NG TEST 20759902122

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2013-01-31 for COBAS AMPLICOR CT/NG TEST 20759902122 manufactured by Roche Molecular Systems.

Event Text Entries

[3280467] A customer from the us filed a complaint alleging that a (b)(6) result was generated for one sample while using the cobas amplicor (b)(6) test for (b)(6). No information regarding the patient was provided. Sample id (b)(4) was initially negative on (b)(6) 2012 and was repeated on (b)(6) 2013 (both results were (b)(6)). The sample type was a male swab. No other test method was used to confirm the results.
Patient Sequence No: 1, Text Type: D, B5


[10374921] Result: device performed according to specifications conclusion: it cannot be definitively determined what the true cause of the discrepant results is. The sample was sent for investigative testing. Three replicates of the sample were analyzed using the. Cobas amplicor test for (b)(6). One sample was (b)(6), one was negative for (b)(6) and one generated equivocal results. Retain testing of the complaint kit lot met specifications. It is unknown if the patient was symptomatic or asymptomatic. In the procedural limitations section of the test's package insert, it is stated that "although evaluated with urine from females and swabs from asymptomatic males, the cobas amplicor test for (b)(6) had reduced performance and is not recommended for testing female urine specimens or asymptomatic male swab specimens. " as no patient information was provided for the male swab specimen in question, it cannot be determined if this may have played a role in the generation of the discrepant results. In addition, the package insert states "additional testing is recommended in any circumstance when (b)(6) or false negative results could lead to adverse medical, social or psychological consequences. " no additional testing was performed by the customer. It cannot be definitively determined what the true cause of the discrepant results is. Retain testing of the complaint kit lot met specifications. The cause of the discrepant results in this complaint may likely be sample specific. There is no indication of a product non-conformance. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2013-00001
MDR Report Key2937854
Report Source05
Date Received2013-01-31
Date of Report2013-01-03
Date of Event2012-12-31
Date Mfgr Received2013-01-03
Device Manufacturer Date2011-02-16
Date Added to Maude2013-04-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLICOR CT/NG TEST
Generic NameDNA PROBE, NUCLEIC ACID AMPLIFICATION, NEISSERIA
Product CodeLSL
Date Received2013-01-31
Catalog Number20759902122
Lot NumberR02623
Device Expiration Date2013-12-31
OperatorHEALTH PROFESSIONAL
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2013-01-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.